Uroplasty, Inc. (UPI) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-5.38M
Depreciation and amortization	207.01K
Loss on disposal of equipment
Amortization of premium on marketable securities	311
Share-based consulting expense
Share-based compensation expense	1.08M
Deferred income taxes	5.13K
Deferred rent	23.56K
Accounts receivable, net	220K
Inventories	73.63K
Other current assets	48.14K
Accounts payable	295.11K
Accrued liabilities
Accrued pension liability, net	-56.23K
Net cash used in operating activities
Proceeds from maturity of marketable securities
Purchases of marketable securities
Purchases of property, plant and equipment	-206.5K
Purchase of intangible assets	0
Proceeds from sale of property, plant and equipment	3.1K
Net cash provided (used in) by investing activities
Net proceeds from exercise of warrants and options
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents	-95.82K
Net decrease in cash and cash equivalents	22.18K
Cash and cash equivalents at beginning of period	8.68M
Cash and cash equivalents at end of period	8.7M
Cash (paid) received during the period for income taxes	56.14K

Entities mentioned with UPI

View All Entities